Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1597

Introduced
3/14/23  
Refer
3/14/23  

Caption

William and James Wonacott Act of 2023

Impact

If enacted, HB1597 would have a profound impact on federal laws related to drug enforcement, particularly concerning fentanyl—a substance that has been a significant contributor to the opioid crisis in the United States. The bill's enhanced penalties are aimed at addressing the increasing prevalence of fentanyl-related overdoses, which have drastically risen in recent years. Proponents of the bill believe that by increasing penalties, the legislation will effectively deter distributors and contribute to declining rates of substance abuse and associated fatalities. However, there are concerns that such harsh penalties may not address the root causes of addiction and could lead to disproportionate incarceration rates for non-violent offenders.

Summary

House Bill 1597, officially known as the William and James Wonacott Act of 2023, aims to amend the Controlled Substances Act to introduce stricter penalties for the distribution of illicit fentanyl and fentanyl-related substances. This bill focuses specifically on substances that contain two milligrams or more of illicit fentanyl, proposing severe penalties for individuals involved in their sale or distribution without the recipient's knowledge. The bill establishes a minimum imprisonment term of 20 years for violations that do not result in death, escalating to a minimum of 25 years if such a violation leads to a fatal outcome. Moreover, the potential for life imprisonment reflects the bill's intent to deter illicit activity surrounding these dangerous substances significantly.

Conclusion

Ultimately, HB1597 represents a significant legislative effort to respond to the fentanyl crisis, highlighting the growing urgency among lawmakers to address drug-related offenses with more robust legal frameworks. The implications of this bill for state and federal law enforcement practices could reshape how drug offenses are prosecuted in the future, making it a critical point of discussion in ongoing legislative commitments to public health and safety.

Contention

The discussion around HB1597 may prove contentious due to the prescribed severity of the penalties. Critics may argue that while the intent of the bill is to combat the opioid epidemic, excessive penalties could exacerbate problems within the criminal justice system rather than help affected individuals. Additionally, opponents may express concern regarding the potential for overreach in law enforcement and the implications such strict penalties could have on communities that are already struggling with high rates of addiction. The language of the bill also raises questions about the balance between public safety and individual rights, especially in cases where the distribution does not lead to death.

Companion Bills

No companion bills found.

Previously Filed As

US HB1580

CEASE Overdose Act of 2023 Continuous and Enduring Action to Stop Every Overdose Act of 2023

US SB1785

Stop Fentanyl Overdoses Act of 2023

US HR39

Expressing the sense of the House of Representatives that illicit fentanyl-related substances are a weapon of mass destruction and should be classified as such.

US SB614

Protecting Americans from Fentanyl Trafficking Act of 2023

US HB171

Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act This bill places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Additionally, the bill establishes a new, alternative registration process for schedule I research that is funded by the Department of Health and Human Services or the Department of Veterans Affairs or that is conducted under an investigative new drug exemption from the Food and Drug Administration. The bill also makes several other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain circumstances, waiving the requirement for a new inspection in certain situations, and allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.

US SB1048

Ending the NARCOS Act of 2023 Ending the Notorious, Aggressive, and Remorseless Criminal Organizations and Syndicates Act of 2023

US HB3359

Disrupt Fentanyl Trafficking Act of 2023

US HB3244

Stop Fentanyl Money Laundering Act of 2023

US HB1076

Preventing the Financing of Illegal Synthetic Drugs Act

US SB2059

Strengthening Sanctions on Fentanyl Traffickers Act of 2023

Similar Bills

CA AB1673

California Fentanyl Abuse Task Force.

CA SB19

Fentanyl Misuse and Overdose Prevention Task Force.

CA AB33

Fentanyl Misuse and Overdose Prevention Task Force.

CA AB3224

California Fentanyl Abuse Task Force.

CA AB675

Controlled substances.

CA AB3171

Controlled substances: fentanyl.

CA AB2341

Criminal procedure: sentencing credits.

NJ ACR168

Urges Congress to enact the "HALT Fentanyl Act."